Stress Management for Cardiovascular Disease
Trial Summary
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It focuses on stress management for women living with HIV, so it's best to ask the trial organizers for more details.
What data supports the effectiveness of the Stress Management and Resiliency Training Program treatment for cardiovascular disease?
Research shows that stress management and lifestyle programs can improve heart health by reducing stress and emotional distress, which are risk factors for heart disease. Additionally, stress-relieving programs have been linked to fewer deaths in heart disease patients, suggesting they can be beneficial for heart health.12345
Is stress management training safe for people with cardiovascular disease?
Stress management programs, like those using biofeedback, have been used safely in various settings, including workplaces, to improve health behaviors and performance. Additionally, cardiac rehabilitation programs that include stress management components have been shown to reduce mortality and improve health outcomes, suggesting they are generally safe for people with cardiovascular conditions.36789
How does the Stress Management and Resiliency Training Program differ from other treatments for cardiovascular disease?
The Stress Management and Resiliency Training (SMART) Program is unique because it focuses on reducing stress and anxiety through educational and relaxation strategies, which can be delivered online or in-person. Unlike traditional treatments that may focus on medication or physical interventions, SMART aims to improve mental well-being, which can indirectly benefit cardiovascular health.210111213
What is the purpose of this trial?
Women living with HIV have 2-4x higher risk for cardiovascular disease compared to women without HIV, with women living with HIV in the Southern US being particularly at risk. While an increased prevalence of traditional risk factors (e.g., hypertension, diabetes, and obesity) partially explain this risk, evidence suggests that increased exposure to structural and social stressors (e.g., poverty, discrimination, and stigma) among women living with HIV in the South negatively contribute to cardiovascular disease disparities through their impact on stress. The Stress Management and Resiliency Training (SMART) program is an effective, evidence-based intervention proven to improve resiliency to environmental stressors and reduce the physiologic responses to stress which contribute to cardiovascular disease. While the SMART program has demonstrated efficacy in a wide range of populations and settings, it has not been designed for or tested among women living with HIV in the South, where unique cultural and faith-based context may diminish the uptake and value of the intervention to mitigate cardiovascular disease risk. The purpose of this study is to adapt the evidence-based SMART program in consideration of the needs and contexts of women living with HIV in the Southern US and pilot the adapted intervention to establish the feasibility, acceptability, and preliminary impact of the adapted intervention to reduce stress and mitigate cardiovascular disease risk among this population.
Eligibility Criteria
This trial is for women living with HIV in the Southern US, who are at higher risk for cardiovascular disease. It aims to help those dealing with stress-related health issues like high blood pressure and sleep apnea. Participants should be experiencing stressors such as poverty or discrimination that could impact their heart health.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive the adapted SMART program intervention to reduce stress and mitigate cardiovascular disease risk
Follow-up
Participants are monitored for changes in resilience, blood pressure, depression, stress, and anxiety
Treatment Details
Interventions
- Stress Management and Resiliency Training Program
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Alabama at Birmingham
Lead Sponsor
National Heart, Lung, and Blood Institute (NHLBI)
Collaborator